NCT02164513 · Interventional trial
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Overall registry status Completed
Phase 3
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- GSK Investigational Site · Downingtown, PA · Chester County
- GSK Investigational Site · Doylestown, PA · Bucks County
- GSK Investigational Site · Marlton, NJ · Burlington County
- GSK Investigational Site · Moorestown, NJ · Burlington County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory